DCF — TRISTAR CENTENNIAL MEDICAL CENTER
Enterprise Value: $632.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$632.1M
Enterprise Value
$160.9M
PV of Cash Flows
$471.2M
PV of Terminal Value
$758.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.0B | $86.8M | 8.0% | $28.3M | $25.7M |
| Year 2 | $1.1B | $100.0M | 9.0% | $37.0M | $30.6M |
| Year 3 | $1.1B | $113.8M | 10.0% | $46.2M | $34.7M |
| Year 4 | $1.1B | $122.8M | 11.0% | $51.8M | $35.4M |
| Year 5 | $1.1B | $129.4M | 11.0% | $55.5M | $34.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $632.1M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$991.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999955637077
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5